SEC 13F Intelligence

Worth Venture Partners, LLC / VKTX

Worth Venture Partners, LLC’s Viking Therapeutics Inc Position

Does Worth Venture Partners, LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 10.1K shares worth $535,401 in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$535,401
Q2 2024
Shares
10.1K
% of Portfolio
+3.97%
Quarters Held
1
position exited

Position History VKTX

Reported value by quarter
Q2 ’24: $535,401Q2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202410.1K$535,401+3.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Worth Venture Partners, LLC’s full portfolio or all institutional holders of VKTX.